• Subscribe
  • About us
  • Advertise with us

NeuroSens

Menu

Skip to content
  • Home
  • Neurology
  • Psychiatry

Topic: EPILEPSY

Adjunctive therapy in focal epilepsy – highlights from AES 2025

December 23, 2025  

Management of refractory epilepsy: highlights from ILAE 2025

October 29, 2025  

Epilepsy Management 2025: Use of Adjunctive Therapies in Practice

May 22, 2025  

Adjunctive cenobamate for focal epilepsy – data review and use in clinical practice

February 11, 2025  

New advances in epilepsy: highlights from AES 2024

December 17, 2024  

Cenobamate as adjunctive therapy for partial-onset seizures: a review

October 25, 2024  

ECTRIMS 2024 HIGHLIGHTS – FRIDAY, SEPTEMBER 20, 2024

September 20, 2024  

Meta-analysis of CBD meta-analyses reports efficacy in younger patients with seizure disorders

August 26, 2024  

What is the seizure risk after stopping antiseizure medications?

August 5, 2024  

REPORT FROM EAN 2024 – WEDNESDAY, JULY 3, 2024

July 3, 2024  
1
2
3
4

Browse by Topic

  • CLINICAL CASES (19)
  • ACTRIMS Forum 2026 (4)
  • MS (433)
  • AES 2025 (1)
  • EPILEPSY (38)
  • BIOMARKERS IN MS (61)
  • ECTRIMS 2025 (7)
  • Library (18)
  • EAN 2025 (2)
  • AAN 2025 (5)
  • ACTRIMS 2025 (6)
  • AES 2024 (1)
  • ECTRIMS 2024 (6)
  • EAN 2024 (3)
  • AD (85)
  • AAN 2024 (5)
  • ACTRIMS Forum 2024 (2)
  • PD (77)
  • COVID-19 (58)
  • MIGRAINE (25)
  • DEPRESSION (36)
  • STROKE (22)
  • SCHIZOPHRENIA (25)
  • DEMENTIA (10)
  • SLEEP (2)
  • PAIN (3)
  • BPD (4)
  • ALS (1)

Popular Posts

  • Ultomiris (ravulizumab) now publicly reimbursed in gMG posted on April 7, 2026
  • Proton pump inhibitors linked to neurological conditions posted on November 29, 2019
  • Treatment initiation with ofatumumab: ACTRIMS Forum 2026 highlights posted on February 19, 2026
Copyright 2026 Lind Publishing Inc All rights reserved. Developed by Integration New Media, INC. (INM)
Contact Us Terms and Conditions